FBLG FY 2025 Earnings — FibroBiologics, Inc. Common Stock Revenue & Financial Results | Market Cap Arena

FBLGFibroBiologics, Inc. Common Stock

$17M

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$832,000

Operating Income

-$17M

Net Income

-$19M

EPS (Diluted)

$-0.42

Cash Flow

Operating Cash Flow

-$16M

Free Cash Flow

-$17M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$10M

Total Liabilities

$3M

Stockholders' Equity

$6M

Cash & Equivalents

$5M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$832,000	$0	—
Operating Income	-$17M	-$14M	-21.2%
Net Income	-$19M	-$11M	-67.1%